Filter by:
Blood-Based Biomarkers May Predict Disease Response in Advanced Urothelial Carcinoma
CancerNetwork |
PSE boosts PSA accuracy from 55% to 94% for confirming the presence or absence of prostate cancer. The highly accurate blood test is simple to order by a physician and is available to men in the US and UK under the immediate access program.